Kathy Mikulec

1.1k total citations
46 papers, 919 citations indexed

About

Kathy Mikulec is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Kathy Mikulec has authored 46 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Surgery. Recurrent topics in Kathy Mikulec's work include Bone health and treatments (13 papers), Bone fractures and treatments (12 papers) and Bone health and osteoporosis research (10 papers). Kathy Mikulec is often cited by papers focused on Bone health and treatments (13 papers), Bone fractures and treatments (12 papers) and Bone health and osteoporosis research (10 papers). Kathy Mikulec collaborates with scholars based in Australia, United States and Switzerland. Kathy Mikulec's co-authors include David G. Little, Aaron Schindeler, Lauren Peacock, Alyson Morse, Michelle M. McDonald, Nicole Yu, Craig Godfrey, Tegan L. Cheng, Laurence C. Cantrill and Ciara M. Murphy and has published in prestigious journals such as Journal of Bone and Joint Surgery, Human Molecular Genetics and Clinical Orthopaedics and Related Research.

In The Last Decade

Kathy Mikulec

43 papers receiving 902 citations

Peers

Kathy Mikulec
Daniel Toben Germany
Paula Kolar Germany
Tamiyo Kon Japan
Jennifer L. Fitch United States
Ming K. Chang Australia
Qing Luo China
Michael I. Dishowitz United States
Shirley Lieu United States
Nick L. Occleston United Kingdom
Girish Ramaswamy United States
Daniel Toben Germany
Kathy Mikulec
Citations per year, relative to Kathy Mikulec Kathy Mikulec (= 1×) peers Daniel Toben

Countries citing papers authored by Kathy Mikulec

Since Specialization
Citations

This map shows the geographic impact of Kathy Mikulec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Mikulec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Mikulec more than expected).

Fields of papers citing papers by Kathy Mikulec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Mikulec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Mikulec. The network helps show where Kathy Mikulec may publish in the future.

Co-authorship network of co-authors of Kathy Mikulec

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Mikulec. A scholar is included among the top collaborators of Kathy Mikulec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Mikulec. Kathy Mikulec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Summers, Matthew A., et al.. (2018). Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse. Molecular Genetics and Metabolism. 123(4). 518–525. 9 indexed citations
2.
Summers, Matthew A., Thusitha Rupasinghe, Frances J. Evesson, et al.. (2017). Dietary intervention rescues myopathy associated with neurofibromatosis type 1. Human Molecular Genetics. 27(4). 577–588. 19 indexed citations
3.
Summers, Matthew A., Kathy Mikulec, Lauren Peacock, David G. Little, & Aaron Schindeler. (2017). Limitations of the Pax7-creER T2 transgene for driving deletion of Nf1 in adult mouse muscle. The International Journal of Developmental Biology. 61(8-9). 531–536. 2 indexed citations
4.
Morse, Alyson, Michelle M. McDonald, Aaron Schindeler, et al.. (2017). Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model. Calcified Tissue International. 101(2). 217–228. 14 indexed citations
5.
Little, David G., Lauren Peacock, Kathy Mikulec, et al.. (2017). Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta. Bone. 101. 96–103. 27 indexed citations
6.
Matthews, Brya G., et al.. (2015). Lineage tracking of mesenchymal and endothelial progenitors in BMP-induced bone formation. Bone. 81. 53–59. 11 indexed citations
7.
Schindeler, Aaron, Nicole Yu, Tegan L. Cheng, et al.. (2015). Local Delivery of the Cationic Steroid Antibiotic CSA-90 Enables Osseous Union in a Rat Open Fracture Model of Staphylococcus aureus Infection. Journal of Bone and Joint Surgery. 97(4). 302–309. 27 indexed citations
8.
Murphy, Ciara M., Aaron Schindeler, John P. Gleeson, et al.. (2014). A collagen–hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acta Biomaterialia. 10(5). 2250–2258. 105 indexed citations
9.
10.
Mikulec, Kathy, et al.. (2014). Inducible cell labeling and lineage tracking during fracture repair. Development Growth & Differentiation. 57(1). 10–23. 15 indexed citations
11.
Jackson, M.T., Kathy Mikulec, Michelle M. McDonald, et al.. (2013). Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). Bone. 59. 151–161. 24 indexed citations
12.
McDonald, Michelle M., Alyson Morse, Kathy Mikulec, et al.. (2013). Matrix Metalloproteinase–Driven Endochondral Fracture Union Proceeds Independently of Osteoclast Activity. Journal of Bone and Mineral Research. 28(7). 1550–1560. 26 indexed citations
13.
Schindeler, Aaron, Lauren Peacock, Kathy Mikulec, et al.. (2013). Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation. European Cells and Materials. 25. 190–203. 21 indexed citations
14.
Schindeler, Aaron, et al.. (2010). In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-lactic acid. European Cells and Materials. 20. 431–442. 26 indexed citations
15.
McDonald, Michelle M., Alyson Morse, Lauren Peacock, et al.. (2010). Characterization of the bone phenotype and fracture repair in osteopetrotic Incisors absent rats. Journal of Orthopaedic Research®. 29(5). 726–733. 14 indexed citations
16.
Birke, Oliver, Aaron Schindeler, Manoj Ramachandran, et al.. (2010). TREATMENT OF CONGENITAL PSEUDARTHROSIS OF THE TIBIA USING RECOMBINANT BONE MORPHOGENETIC PROTEIN AND BISPHOSPHONATES. Bone. 46. S20–S21. 1 indexed citations
17.
Tägil, Magnus, Michelle M. McDonald, Alyson Morse, et al.. (2009). Intermittent PTH(1–34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Bone. 46(3). 852–859. 64 indexed citations
18.
Yu, Nicole, Andrew J. Ruys, Craig Godfrey, et al.. (2008). Bisphosphonate‐laden acrylic bone cement: Mechanical properties, elution performance, and in vivo activity. Journal of Biomedical Materials Research Part B Applied Biomaterials. 87B(2). 482–491. 15 indexed citations
19.
Schindeler, Aaron, Alyson Morse, Lorraine Harry, et al.. (2008). Models of tibial fracture healing in normal and Nf1‐deficient mice. Journal of Orthopaedic Research®. 26(8). 1053–1060. 53 indexed citations
20.
Schindeler, Aaron, Manoj Ramachandran, Craig Godfrey, et al.. (2007). Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild‐type and Nf1 haploinsufficient mice. Journal of Orthopaedic Research®. 26(1). 65–74. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Toben Breakdown of academic impact, for papers by Paula Kolar Breakdown of academic impact, for papers by Tamiyo Kon Breakdown of academic impact, for papers by Jennifer L. Fitch Breakdown of academic impact, for papers by Ming K. Chang Breakdown of academic impact, for papers by Qing Luo Breakdown of academic impact, for papers by Michael I. Dishowitz Breakdown of academic impact, for papers by Shirley Lieu Breakdown of academic impact, for papers by Nick L. Occleston Breakdown of academic impact, for papers by Girish Ramaswamy
Rankless by CCL
2026